搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Arthroderma gypseum Leucine aminopeptidase 1 (LAP1) CSB-YP517196DOO
CSB-EP517196DOO
CSB-BP517196DOO
CSB-MP517196DOO
CSB-EP517196DOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Leptosphaeria maculans Vacuolar protein sorting/targeting protein 10 (VPS10), partial CSB-YP517197LOP
CSB-EP517197LOP
CSB-BP517197LOP
CSB-MP517197LOP
CSB-EP517197LOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Leptosphaeria maculans Long chronological lifespan protein 2 (LCL2) CSB-YP517198LOP
CSB-EP517198LOP
CSB-BP517198LOP
CSB-MP517198LOP
CSB-EP517198LOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ostrinia nubilalis Sensory neuron membrane protein 2 (Snmp2), partial CSB-YP517199OFQ
CSB-EP517199OFQ
CSB-BP517199OFQ
CSB-MP517199OFQ
CSB-EP517199OFQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Staphylococcus aureus Riboflavin transporter RibU (ribU), partial CSB-YP517200FLH1
CSB-EP517200FLH1
CSB-BP517200FLH1
CSB-MP517200FLH1
CSB-EP517200FLH1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma gypseum Tethering factor for nuclear proteasome STS1 (STS1) CSB-YP517201DOO
CSB-EP517201DOO
CSB-BP517201DOO
CSB-MP517201DOO
CSB-EP517201DOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Formiminotransferase N-terminal subdomain-containing protein (FONG) CSB-YP517202HU
CSB-EP517202HU
CSB-BP517202HU
CSB-MP517202HU
CSB-EP517202HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudoalteromonas sp. 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA (cpdA) CSB-YP517203EZU
CSB-EP517203EZU
CSB-BP517203EZU
CSB-MP517203EZU
CSB-EP517203EZU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfurispirillum indicum Protein translocase subunit SecD (secD), partial CSB-YP517204DJS1
CSB-EP517204DJS1
CSB-BP517204DJS1
CSB-MP517204DJS1
CSB-EP517204DJS1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhopalurus junceus Putative beta-neurotoxin RjAa8 CSB-YP517205RMG
CSB-EP517205RMG
CSB-BP517205RMG
CSB-MP517205RMG
CSB-EP517205RMG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhopalurus junceus Putative beta-neurotoxin RjAa32 CSB-YP517206RMG
CSB-EP517206RMG
CSB-BP517206RMG
CSB-MP517206RMG
CSB-EP517206RMG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Monopolar spindle protein 2 (MPS2), partial CSB-YP517207SVI1
CSB-EP517207SVI1
CSB-BP517207SVI1
CSB-MP517207SVI1
CSB-EP517207SVI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Biogenesis of lysosome-related organelles complex 1 subunit BLI1 (BLI1) CSB-YP517208SVI
CSB-EP517208SVI
CSB-BP517208SVI
CSB-MP517208SVI
CSB-EP517208SVI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Genetic interactor of prohibitins 3, mitochondrial (GEP3), partial CSB-YP517209SVI
CSB-EP517209SVI
CSB-BP517209SVI
CSB-MP517209SVI
CSB-EP517209SVI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Biogenesis of lysosome-related organelles complex 1 subunit CNL1 (CLN1) CSB-YP517210SVO
CSB-EP517210SVO
CSB-BP517210SVO
CSB-MP517210SVO
CSB-EP517210SVO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Mitochondrial morphogenesis protein SLD7 (SLD7) CSB-YP517211SVO
CSB-EP517211SVO
CSB-BP517211SVO
CSB-MP517211SVO
CSB-EP517211SVO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae High osmolarity signaling protein SHO1 (SHO1), partial CSB-YP517212SVQ1
CSB-EP517212SVQ1
CSB-BP517212SVQ1
CSB-MP517212SVQ1
CSB-EP517212SVQ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Ribosomal N-lysine methyltransferase 5 (RKM5) CSB-YP517213SVQ
CSB-EP517213SVQ
CSB-BP517213SVQ
CSB-MP517213SVQ
CSB-EP517213SVQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Suppressor of hydroxyurea sensitivity protein 2 (SHU2) CSB-YP517214SVK
CSB-EP517214SVK
CSB-BP517214SVK
CSB-MP517214SVK
CSB-EP517214SVK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Topoisomerase I damage affected protein 11 (TDA11) CSB-YP517215SVK
CSB-EP517215SVK
CSB-BP517215SVK
CSB-MP517215SVK
CSB-EP517215SVK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>